We use state-of-the-art screening methods to develop our products based on in-depth knowledge on their chemical composition and mixing ratios – thereby creating synergistically optimised, pre- and symbiotic formulas.
Our proprietary formulations are developed and functionally validated to modulate specific microbial communities within the gut. These are both directly and indirectly involved in maintaining a healthy state of neurotransmitter biosynthesis and anti-inflammatory pathways.
PROGNOSTIC PATTERN RECOGNITION
Our meta-analysis platform is fed with a multitude of clinical data sets derived from 30+ chronic inflammatory diseases and is fueled by an AI-driven pattern recognition algorithm. This allows us to build innovative and digital health and disease risk assessment platform.
Our broad and constantly expanding formulation library addresses the diversity of the gut microbiome and allows for development of precision supplementation products and nutrition plans – by means of individualised gut modulation.